Boothbay Fund Management, LLC Cassava Sciences Inc Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$12.64 - $30.11 $151,680 - $361,320
12,000 New
12,000 $270,000
Q2 2020

Aug 14, 2020
SELL
$2.04 - $9.64 $78,246 - $369,751
-38,356 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$3.26 - $9.65 $125,040 - $370,135
38,356 New
38,356 $158,000
Q3 2019

Nov 14, 2019
SELL
$1.04 - $1.45 $19,988 - $27,869
-19,220 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$1.02 - $1.34 $19,604 - $25,754
19,220 New
19,220 $23,000

Others Institutions Holding SAVA

# of Institutions
184
Shares Held
13.3M
Call Options Held
1.38M
Put Options Held
2.04M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.22B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email